Tramadol Prescription over a 4-Year Period in the USA
Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Bigal, Luisa M. [verfasserIn] Bibeau, Kristen [verfasserIn] Dunbar, Stephanie [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Current Review of Pain - Current Medicine Group, 1998, 23(2019), 10 vom: 06. Aug. |
|---|---|
| Übergeordnetes Werk: |
volume:23 ; year:2019 ; number:10 ; day:06 ; month:08 |
| Links: |
|---|
| DOI / URN: |
10.1007/s11916-019-0777-x |
|---|
| Katalog-ID: |
SPR023013257 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR023013257 | ||
| 003 | DE-627 | ||
| 005 | 20201125053718.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11916-019-0777-x |2 doi | |
| 035 | |a (DE-627)SPR023013257 | ||
| 035 | |a (SPR)s11916-019-0777-x-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bigal, Luisa M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tramadol Prescription over a 4-Year Period in the USA |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. | ||
| 650 | 4 | |a Tramadol |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Opioids |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prescription rates |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prescription patterns |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Bibeau, Kristen |e verfasserin |4 aut | |
| 700 | 1 | |a Dunbar, Stephanie |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current Review of Pain |d Current Medicine Group, 1998 |g 23(2019), 10 vom: 06. Aug. |w (DE-627)SPR023001666 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2019 |g number:10 |g day:06 |g month:08 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11916-019-0777-x |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_252 | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2019 |e 10 |b 06 |c 08 | ||
| author_variant |
l m b lm lmb k b kb s d sd |
|---|---|
| matchkey_str |
bigalluisambibeaukristendunbarstephanie:2019----:rmdlrsrpinvr4ere |
| hierarchy_sort_str |
2019 |
| publishDate |
2019 |
| allfields |
10.1007/s11916-019-0777-x doi (DE-627)SPR023013257 (SPR)s11916-019-0777-x-e DE-627 ger DE-627 rakwb eng Bigal, Luisa M. verfasserin aut Tramadol Prescription over a 4-Year Period in the USA 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. Tramadol (dpeaa)DE-He213 Opioids (dpeaa)DE-He213 Prescription rates (dpeaa)DE-He213 Prescription patterns (dpeaa)DE-He213 Bibeau, Kristen verfasserin aut Dunbar, Stephanie verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 23(2019), 10 vom: 06. Aug. (DE-627)SPR023001666 nnns volume:23 year:2019 number:10 day:06 month:08 https://dx.doi.org/10.1007/s11916-019-0777-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_73 GBV_ILN_252 AR 23 2019 10 06 08 |
| spelling |
10.1007/s11916-019-0777-x doi (DE-627)SPR023013257 (SPR)s11916-019-0777-x-e DE-627 ger DE-627 rakwb eng Bigal, Luisa M. verfasserin aut Tramadol Prescription over a 4-Year Period in the USA 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. Tramadol (dpeaa)DE-He213 Opioids (dpeaa)DE-He213 Prescription rates (dpeaa)DE-He213 Prescription patterns (dpeaa)DE-He213 Bibeau, Kristen verfasserin aut Dunbar, Stephanie verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 23(2019), 10 vom: 06. Aug. (DE-627)SPR023001666 nnns volume:23 year:2019 number:10 day:06 month:08 https://dx.doi.org/10.1007/s11916-019-0777-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_73 GBV_ILN_252 AR 23 2019 10 06 08 |
| allfields_unstemmed |
10.1007/s11916-019-0777-x doi (DE-627)SPR023013257 (SPR)s11916-019-0777-x-e DE-627 ger DE-627 rakwb eng Bigal, Luisa M. verfasserin aut Tramadol Prescription over a 4-Year Period in the USA 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. Tramadol (dpeaa)DE-He213 Opioids (dpeaa)DE-He213 Prescription rates (dpeaa)DE-He213 Prescription patterns (dpeaa)DE-He213 Bibeau, Kristen verfasserin aut Dunbar, Stephanie verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 23(2019), 10 vom: 06. Aug. (DE-627)SPR023001666 nnns volume:23 year:2019 number:10 day:06 month:08 https://dx.doi.org/10.1007/s11916-019-0777-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_73 GBV_ILN_252 AR 23 2019 10 06 08 |
| allfieldsGer |
10.1007/s11916-019-0777-x doi (DE-627)SPR023013257 (SPR)s11916-019-0777-x-e DE-627 ger DE-627 rakwb eng Bigal, Luisa M. verfasserin aut Tramadol Prescription over a 4-Year Period in the USA 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. Tramadol (dpeaa)DE-He213 Opioids (dpeaa)DE-He213 Prescription rates (dpeaa)DE-He213 Prescription patterns (dpeaa)DE-He213 Bibeau, Kristen verfasserin aut Dunbar, Stephanie verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 23(2019), 10 vom: 06. Aug. (DE-627)SPR023001666 nnns volume:23 year:2019 number:10 day:06 month:08 https://dx.doi.org/10.1007/s11916-019-0777-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_73 GBV_ILN_252 AR 23 2019 10 06 08 |
| allfieldsSound |
10.1007/s11916-019-0777-x doi (DE-627)SPR023013257 (SPR)s11916-019-0777-x-e DE-627 ger DE-627 rakwb eng Bigal, Luisa M. verfasserin aut Tramadol Prescription over a 4-Year Period in the USA 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. Tramadol (dpeaa)DE-He213 Opioids (dpeaa)DE-He213 Prescription rates (dpeaa)DE-He213 Prescription patterns (dpeaa)DE-He213 Bibeau, Kristen verfasserin aut Dunbar, Stephanie verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 23(2019), 10 vom: 06. Aug. (DE-627)SPR023001666 nnns volume:23 year:2019 number:10 day:06 month:08 https://dx.doi.org/10.1007/s11916-019-0777-x lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_73 GBV_ILN_252 AR 23 2019 10 06 08 |
| language |
English |
| source |
Enthalten in Current Review of Pain 23(2019), 10 vom: 06. Aug. volume:23 year:2019 number:10 day:06 month:08 |
| sourceStr |
Enthalten in Current Review of Pain 23(2019), 10 vom: 06. Aug. volume:23 year:2019 number:10 day:06 month:08 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Tramadol Opioids Prescription rates Prescription patterns |
| isfreeaccess_bool |
false |
| container_title |
Current Review of Pain |
| authorswithroles_txt_mv |
Bigal, Luisa M. @@aut@@ Bibeau, Kristen @@aut@@ Dunbar, Stephanie @@aut@@ |
| publishDateDaySort_date |
2019-08-06T00:00:00Z |
| hierarchy_top_id |
SPR023001666 |
| id |
SPR023013257 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR023013257</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20201125053718.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11916-019-0777-x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR023013257</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11916-019-0777-x-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bigal, Luisa M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tramadol Prescription over a 4-Year Period in the USA</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tramadol</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Opioids</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription rates</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription patterns</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bibeau, Kristen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dunbar, Stephanie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current Review of Pain</subfield><subfield code="d">Current Medicine Group, 1998</subfield><subfield code="g">23(2019), 10 vom: 06. Aug.</subfield><subfield code="w">(DE-627)SPR023001666</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:10</subfield><subfield code="g">day:06</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11916-019-0777-x</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2019</subfield><subfield code="e">10</subfield><subfield code="b">06</subfield><subfield code="c">08</subfield></datafield></record></collection>
|
| author |
Bigal, Luisa M. |
| spellingShingle |
Bigal, Luisa M. misc Tramadol misc Opioids misc Prescription rates misc Prescription patterns Tramadol Prescription over a 4-Year Period in the USA |
| authorStr |
Bigal, Luisa M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR023001666 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Tramadol Prescription over a 4-Year Period in the USA Tramadol (dpeaa)DE-He213 Opioids (dpeaa)DE-He213 Prescription rates (dpeaa)DE-He213 Prescription patterns (dpeaa)DE-He213 |
| topic |
misc Tramadol misc Opioids misc Prescription rates misc Prescription patterns |
| topic_unstemmed |
misc Tramadol misc Opioids misc Prescription rates misc Prescription patterns |
| topic_browse |
misc Tramadol misc Opioids misc Prescription rates misc Prescription patterns |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Current Review of Pain |
| hierarchy_parent_id |
SPR023001666 |
| hierarchy_top_title |
Current Review of Pain |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR023001666 |
| title |
Tramadol Prescription over a 4-Year Period in the USA |
| ctrlnum |
(DE-627)SPR023013257 (SPR)s11916-019-0777-x-e |
| title_full |
Tramadol Prescription over a 4-Year Period in the USA |
| author_sort |
Bigal, Luisa M. |
| journal |
Current Review of Pain |
| journalStr |
Current Review of Pain |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
txt |
| author_browse |
Bigal, Luisa M. Bibeau, Kristen Dunbar, Stephanie |
| container_volume |
23 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Bigal, Luisa M. |
| doi_str_mv |
10.1007/s11916-019-0777-x |
| author2-role |
verfasserin |
| title_sort |
tramadol prescription over a 4-year period in the usa |
| title_auth |
Tramadol Prescription over a 4-Year Period in the USA |
| abstract |
Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. |
| abstractGer |
Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. |
| abstract_unstemmed |
Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER GBV_ILN_73 GBV_ILN_252 |
| container_issue |
10 |
| title_short |
Tramadol Prescription over a 4-Year Period in the USA |
| url |
https://dx.doi.org/10.1007/s11916-019-0777-x |
| remote_bool |
true |
| author2 |
Bibeau, Kristen Dunbar, Stephanie |
| author2Str |
Bibeau, Kristen Dunbar, Stephanie |
| ppnlink |
SPR023001666 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s11916-019-0777-x |
| up_date |
2024-07-03T16:17:57.706Z |
| _version_ |
1803575338165338112 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR023013257</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20201125053718.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11916-019-0777-x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR023013257</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11916-019-0777-x-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bigal, Luisa M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tramadol Prescription over a 4-Year Period in the USA</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Purpose of Review Deaths associated to tramadol, a synthetic opioid, are rising globally. Herein, we characterize prescription patterns of tramadol relative to other opioids in the USA from 2012 to 2015, by geographic region and physician specialty. Recent Findings Data on opioid was obtained using Truven Health Analytics MarketScan for the years 2012–2015. Inclusion criteria included subjects living in the USA with ages from 12 to 64 years. Patterns of prescription of tramadol were contrasted with other prescription opioids including hydrocodone, codeine, oxycodone, oxymorphone, methadone, and fentanyl. Between 2012 and 2015, prescriptions for tramadol increased by 22.8%. The absolute rate of prescription varies considerably per region, with tramadol representing nearly 20% of opioid prescriptions in the South, which, in turn, represents nearly 50% of all prescriptions in the USA. Significant differences were seen when comparing prescribers of tramadol with other opioids (p < 0.0001). Tramadol was more frequently prescribed by family practice (40% vs. 32%) and internal medicine physicians (19% vs. 16%). Family medicine, internal medicine, and non-physician prescribers responded by 67.2% of all tramadol prescriptions in 2015. The proportion of patients receiving tramadol from non-physician prescribers increased by 56% between 2012 and 2015 (p < 0.001) IOM. Summary Tramadol prescriptions rates have continuously increased both nationally and throughout all US regions. Important differences exist among regions and physician specialties. These results may be helpful in the creation of regional policies to monitor reasons for this increase and to avoid excessive use of tramadol.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tramadol</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Opioids</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription rates</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prescription patterns</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bibeau, Kristen</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dunbar, Stephanie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current Review of Pain</subfield><subfield code="d">Current Medicine Group, 1998</subfield><subfield code="g">23(2019), 10 vom: 06. Aug.</subfield><subfield code="w">(DE-627)SPR023001666</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:10</subfield><subfield code="g">day:06</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11916-019-0777-x</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2019</subfield><subfield code="e">10</subfield><subfield code="b">06</subfield><subfield code="c">08</subfield></datafield></record></collection>
|
| score |
7.4014254 |